hepatitis C

Medical groups question price of new hep C drug
Yahoo/AP
Tue, 03/11/14 - 03:00 pm
Sovaldi
drug pricing
California
Gilead Sciences
hepatitis C
Prices of new hepatitis C drugs are tough to swallow for insurers
LA Times, CA
Mon, 03/10/14 - 08:19 am
insurance
hepatitis C
Sovaldi
Gilead Sciences
Olysio
JNJ
Janssen
Boehringer Ingelheim reports positive phase 3 SVR12 results in HCV/HIV co-infected patients treated with faldaprevir
Pharmabiz
Sat, 03/8/14 - 10:49 am
SVR12
Boehringer Ingelheim
HCV
HIV
hepatitis
hepatitis C
Gilead's Sovaldi sales through the roof already, analyst predicts at least $8B this year
Fierce Pharma
Fri, 03/7/14 - 12:14 pm
Gilead Sciences
Sovaldi
hepatitis C
Costly hepatitis drug Sovaldi rattles industry
Washington Post, DC
Wed, 03/5/14 - 09:06 am
Sovaldi
drug pricing
hepatitis C
Gilead Sciences
Today's Biggest Biotech Stories: Dendreon, AbbVie, and Omeros
Motley Fool
Tue, 03/4/14 - 12:31 pm
Dendreon
AbbVie
Omeros
Provenge
prostate cancer
ABT-450
hepatitis C
OMS721
AbbVie Hepatitis C Combo Cures Almost All in Late Study
Bloomberg
Mon, 03/3/14 - 06:46 pm
AbbVie
hepatitis C
ABT-450
ABT-267
ABT-333
Gilead Sciences
Bristol-Myers Squibb
3 Things to Watch at Gilead
Motley Fool
Tue, 02/25/14 - 07:24 am
Gilead Sciences
Sovaldi
HIV
hepatitis C
Bristol-Myers Squibb Receives U.S. FDA Breakthrough Therapy Designation for All-Oral Daclatasvir Dual Investigational Regimen for Chronic Hepatitis C
Yahoo
Mon, 02/24/14 - 09:55 am
daclatasvir
breakthrough therapies
FDA
Bristol-Myers Squibb
hepatitis C
Gilead: AbbVie No Match For Sovaldi
Barron's
Sat, 02/22/14 - 10:41 am
Gilead Sciences
AbbVie
Sovaldi
hepatitis
hepatitis C
Gilead's Hepatitis C Pill Takes Off Like A Rocket
Forbes
Fri, 02/21/14 - 09:07 am
Sovaldi
Gilead Sciences
hepatitis C
Biotech Stock Roundup: Regeneron's Eylea Impresses, Gilead Files for Next HCV Drug
Yahoo/Zacks.com
Wed, 02/19/14 - 09:26 am
Regeneron
Eylea
Gilead Sciences
ledipasvir
Sovaldi
hepatitis C
Cangrelor
The Medicines Company
Gilead says payers feel comfortable with the cost of Sovaldi
Fierce Pharma
Fri, 02/14/14 - 12:59 pm
Gilead
Sovaldi
insurance
hepatitis C
Gilead Sciences: Sovaldi Exclusion No Big Deal
Barron's
Mon, 02/10/14 - 05:27 pm
Sovaldi
Gilead Sciences
hepatitis C
The Hep C Race Is Heating Up: AbbVie Vs. Gilead
Seeking Alpha
Mon, 02/10/14 - 08:35 am
AbbVie
Gilead Sciences
hepatitis C
Sovaldi
Gilead Sciences, Inc Has a Potential Blockbuster Drug for 2014
Motley Fool
Thu, 02/6/14 - 07:43 am
Gilead Sciences
hepatitis C
Sovaldi
Gilead to license hepatitis C drug to lower-cost manufacturers in India
Yahoo/Reuters
Wed, 02/5/14 - 06:57 pm
hepatitis C
India
Gilead Sciences
Sovaldi
AbbVie's Challenge to Gilead in Hepatitis C Therapies
Motley Fool
Tue, 02/4/14 - 07:00 pm
AbbVie
Gilead Sciences
Sovaldi
hepatitis C
Enanta Pharmaceuticals
ABT-450
This Week in Biotech: Let's Get Clinical!
Motley Fool
Sun, 02/2/14 - 11:30 am
AbbVie
Enanta Pharmaceuticals
ABT-450
hepatitis C
Medivation
Xtandi
prostate cancer
Astellas
Geron
imetelstat
PSMA-ADC
Progenics Pharmaceuticals
Idenix
AbbVie Headed to FDA, Clash With Gilead Set
Motley Fool
Sat, 02/1/14 - 10:49 am
AbbVie
Gilead Sciences
ABT-450
hepatitis
hepatitis C
Enanta Pharmaceuticals

Pages